Bio Preventive Medicine Corp. (TPEX:6810)
Taiwan · Delayed Price · Currency is TWD 17.60
+0.05 (0.28%)
Apr 20, 2026, 1:23 PM CST
Bio Preventive Medicine Market Cap
Bio Preventive Medicine has a market cap or net worth of 870.29 million as of April 20, 2026. Its market cap has decreased by -39.41% in one year.
Market Cap
870.29M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
17.60
Market Cap Chart
Since August 30, 2021, Bio Preventive Medicine's market cap has increased from 711.01M to 870.29M, an increase of 22.40%. That is a compound annual growth rate of 4.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 870.29M | -24.79% |
| Dec 31, 2025 | 1.16B | -22.00% |
| Dec 31, 2024 | 1.48B | 13.92% |
| Dec 29, 2023 | 1.30B | 8.31% |
| Dec 30, 2022 | 1.20B | -4.26% |
| Dec 30, 2021 | 1.26B | 76.61% |
| Aug 30, 2021 | 711.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Meribank Biotech | 1.16B |
| GeneReach Biotechnology | 1.13B |
| Taiwan Advance Bio-Pharmaceutical | 1.13B |
| Level Biotechnology | 1.09B |
| Lukas Biomedical | 1.01B |
| TCI GENE | 967.06M |
| NatureWise Biotech & Medicals | 900.10M |
| BioLASCO Taiwan | 778.60M |